Page 136 - 《中国药房》2023年1期

他药物联用产生协同抗肿瘤效果。随着研究的不断深 lease for multilevel chemotherapy amplification in drug-
入，越来越多的光敏剂被用于构建纳米递送系统。这些 resistant breast cancer[J]. Pharmaceutics， 2022， 14
纳米递送系统不仅可以递送光敏剂，还可以同时递送化 （2）：422.
疗药物，使其具有光疗和化疗的双重作用，极大地提高 [ 9 ] ZHANG H，TANG W L，KHEIROLOMOOM A，et al. De‐
了乳腺癌的治疗效果。相信在未来的研究中，具有多重 velopment of thermosensitive resiquimod-loaded lipo‐
somes for enhanced cancer immunotherapy[J]. J Control
作用的多功能纳米递送系统将会成为抗肿瘤药物研发
Release，2021，330：1080-1094.
的新方向。
[10] LI R，LIN Z，ZHANG Q，et al. Injectable and in situ-
4 结语 formable thiolated chitosan-coated liposomal hydrogels as
乳腺癌的治疗除了上述用于药物治疗、基因治疗及 curcumin carriers for prevention of in vivo breast cancer
光疗的纳米递送系统外，还有其他治疗方法，如磁热治 recurrence[J]. ACS Appl Mater Interfaces，2020，12（15）：
疗、声动力疗法以及放疗等的纳米递送系统也有很多文 17936-17948.
献报道。每种治疗方法各有优势，通过这些纳米系统的 [11] TANG Z，LUO C，JUN Y，et al. Nanovector assembled
递送，都能使各种治疗剂高效准确地蓄积于肿瘤部位， from natural egg yolk lipids for tumor-targeted delivery of
显著提高乳腺癌的治疗效果，同时降低毒副作用。目 therapeutics[J]. ACS Appl Mater Interfaces，2020，12（7）：
前，这些纳米递送系统的药理作用在细胞和动物水平得 7984-7994.
到了证实，但是真正被应用到临床上的却很少。在未来 [12] LANDGRAF M，LAHR C A，KAUR I，et al. Targeted
camptothecin delivery via silicon nanoparticles reduces
的研究中，应加快纳米递送系统在临床上的研究，以期
breast cancer metastasis[J]. Biomaterials，2020，240：
为乳腺癌的治疗提供新方法。
119791.
参考文献
[13] YADAV A S，RADHARANI N N V，GORAIN M，et al.
[ 1 ] ZHONG D，ZHANG D，XIE T，et al. Biodegradable RGD functionalized chitosan nanoparticle mediated tar‐
microalgae-based carriers for targeted delivery and geted delivery of raloxifene selectively suppresses angio‐
imaging-guided therapy toward lung metastasis of breast genesis and tumor growth in breast cancer[J]. Nanoscale，
cancer[J]. Small，2020，16（20）：e2000819. 2020，12（19）：10664-10684.
[ 2 ] WANG Z，ZHAO Y，YANG Z，et al. Construction of intel‐ [14] BHATTACHARYA S，GHOSH A，MAITI S，et al. Delivery
ligent responsive drug delivery system and multi-mode of thymoquinone through hyaluronic acid-decorated
imaging based on gold nanodots[J]. Macromol Rapid mixed pluronic nanoparticles to attenuate angiogenesis
®
Commun，2022，43（10）：e2200034. and metastasis of triple-negative breast cancer[J]. J Con‐
[ 3 ] GUO Z，SUI J，MA M，et al. pH-responsive charge switcha- trol Release，2020，322：357-374.
ble PEGylated ε-poly-l-lysine polymeric nanoparticles- [15] YIN S，GAO Y，ZHANG Y，et al. Reduction/oxidation-
assisted combination therapy for improving breast cancer responsive hierarchical nanoparticles with self-driven de‐
treatment[J]. J Control Release，2020，326：350-364. gradability for enhanced tumor penetration and precise
[ 4 ] SINGH S，GHOSH C，ROY P，et al. Biosynthesis of folic chemotherapy[J]. ACS Appl Mater Interfaces，2020，12
acid appended PHBV modified copper oxide nanorods for （16）：18273-18291.
pH sensitive drug release in targeted breast cancer therapy [16] SHI J，REN Y，MA J，et al. Novel CD44-targeting and pH/
[J]. Int J Pharm，2022，622：121831. redox-dual-stimuli-responsive core-shell nanoparticles
[ 5 ] MA W，SUN J，XU J，et al. Sensitizing triple negative loading triptolide combats breast cancer growth and lung
breast cancer to tamoxifen chemotherapy via a redox- metastasis[J]. J Nanobiotechnology，2021，19（1）：188.
responsive vorinostat-containing polymeric prodrug nano‐ [17] KIM B，SHIN J，WU J，et al. Engineering peptide-targeted
carrier[J]. Theranostics，2020，10（6）：2463-2478. liposomal nanoparticles optimized for improved selecti-
[ 6 ] DONG C，ZHOU Q，XIANG J，et al. Self-assembly of vity for HER2-positive breast cancer cells to achieve en‐
oxidation-responsive polyethylene glycol-paclitaxel pro‐ hanced in vivo efficacy[J]. J Control Release，2020，322：
drug for cancer chemotherapy[J]. J Control Release，2020， 530-541.
321：529-539. [18] QIU Y，RENK，ZHAOW，et al. A “dual-guide” bioin‐
[ 7 ] TANG M X，YANG M J，HE K Y，et al. Glycyrrhetinic spired drug delivery strategy of a macrophage-based car‐
acid remodels the tumor microenvironment and synergizes rier against postoperative triple-negative breast cancer re‐
with doxorubicin for breast cancer treatment in a murine currence[J]. J Control Release，2021，329：191-204.
model[J]. Nanotechnology，2021，32（18）：185702. [19] GONG C，YU X，YOU B，et al. Macrophage-cancer hy‐
[ 8 ] GUO Y，LIU S，LUO F，et al. A nanosized codelivery sys‐ brid membrane-coated nanoparticles for targeting lung me‐
tem based on intracellular stimuli-triggered dual-drug re‐ tastasis in breast cancer therapy[J]. J Nanobiotechnology，

· 126 · China Pharmacy 2023 Vol. 34 No. 1 中国药房 2023年第34卷第1期